Stockreport

GoodRx Reports Third Quarter 2025 Results

GoodRx Holdings, Inc. - Class A  (GDRX) 
PDF Company Maintains Full Year 2025 Revenue and Adjusted EBITDA Expectations; Raises Pharma Manufacturer Solutions Revenue Outlook to Approximately 35% Year-Over-Year Growt [Read more]